Chronic obstructive pulmonary disease (COPD) is an increasing health problem and one of
the leading causes of morbidity and mortality worldwide, but knowledge about its …

Although guidelines recommend combining long-acting bronchodilators in COPD, data are
limited. We examined the clinical efficacy and safety of formoterol, tiotropium and the …

Background Bronchodilator responsiveness (BDR) is commonly used in the diagnosis of
lung disease. Although small airways dysfunction is a feature of asthma and COPD …

This retrospective analysis of data from two multi-center, randomized, double-blind, parallel
group studies compared the efficacy of fluticasone propionate/salmeterol (FSC) 250/50mcg …

Background The purpose of this study was to evaluate the correlation between immediate
responsiveness with the short-acting β 2-agonist salbutamol and effects of treatment with the …

Objective: To evaluate, using pulmonary function tests, the effectiveness of formoterol as a
bronchodilator at 30 min after its administration in patients with poorly reversible COPD …

COPD is an increasing health problem and one of the leading causes of morbidity and
mortality worldwide, but knowledge about its pathogenesis has increased substantially in …

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease that is
linked to high mortality and morbidity. In COPD, the majority of airway resistance is located …

O volume expiratório forçado no primeiro segundo (VEF 1) foi descrito em 1947 por
Tiffeneau e Pinelli em Paris e em 1951 por Gaensler nos EUA.(1-2) A ventilação voluntária …

OBJETIVO: Avaliar, por meio de provas de função pulmonar, a eficácia broncodilatadora do
formoterol após 30 min de sua administração em portadores de doença pulmonar obstrutiva …